Successful Treatment of Ebola Virus-Infected Cynomolgus Macaques with Monoclonal Antibodies

Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease

(2012) J. M. Dye et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection

(2012) Xiangguo Qiu et al.   PLoS Neglected Tropical Diseases

Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies

(2011) Xiangguo Qiu et al.   CLINICAL IMMUNOLOGY

Replication, Pathogenicity, Shedding, and Transmission of Zaire ebolavirus in Pigs

(2011) Gary P. Kobinger et al.   JOURNAL OF INFECTIOUS DISEASES

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

(2011) Nancy J Sullivan et al.   NATURE MEDICINE

A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge

(2011) K. N. Bossart et al.   Science Translational Medicine

Recent advances inEbolavirusvaccine development

(2010) Jason S. Richardson et al.   Human vaccines & immunotherapeutics

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

(2010) Thomas W Geisbert et al.   LANCET

Advanced antisense therapies for postexposure protection against lethal filovirus infections

(2010) Travis K Warren et al.   NATURE MEDICINE

Disease modeling for Ebola and Marburg viruses

(2009) D. Bente et al.   Disease Models & Mechanisms

Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses

(2009) Xiangguo Qiu et al.   PLoS One

Vaccines: Correlates of Vaccine‐Induced Immunity

(2008) Stanley A. Plotkin   CLINICAL INFECTIOUS DISEASES